- Home
- DGICB vs CBLL Comparison
DGICB vs CBLL Comparison
Compare DGICB & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICB
- CBLL
- Stock Information
- Founded
- DGICB 1986
- CBLL 2014
- Country
- DGICB United States
- CBLL United States
- Employees
- DGICB N/A
- CBLL N/A
- Industry
- DGICB Property-Casualty Insurers
- CBLL
- Sector
- DGICB Finance
- CBLL
- Exchange
- DGICB Nasdaq
- CBLL Nasdaq
- Market Cap
- DGICB 605.9M
- CBLL 538.0M
- IPO Year
- DGICB N/A
- CBLL 2024
- Fundamental
- Price
- DGICB $19.40
- CBLL $17.91
- Analyst Decision
- DGICB
- CBLL Strong Buy
- Analyst Count
- DGICB 0
- CBLL 6
- Target Price
- DGICB N/A
- CBLL $33.00
- AVG Volume (30 Days)
- DGICB 419.0
- CBLL 307.7K
- Earning Date
- DGICB 07-24-2025
- CBLL 08-14-2025
- Dividend Yield
- DGICB 3.75%
- CBLL N/A
- EPS Growth
- DGICB 1206.68
- CBLL N/A
- EPS
- DGICB 2.03
- CBLL N/A
- Revenue
- DGICB $993,637,805.00
- CBLL $71,535,000.00
- Revenue This Year
- DGICB $3.27
- CBLL $34.12
- Revenue Next Year
- DGICB $4.01
- CBLL $28.66
- P/E Ratio
- DGICB $9.57
- CBLL N/A
- Revenue Growth
- DGICB 5.29
- CBLL 44.86
- 52 Week Low
- DGICB $10.75
- CBLL $10.01
- 52 Week High
- DGICB $18.83
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- DGICB 67.35
- CBLL N/A
- Support Level
- DGICB $17.00
- CBLL N/A
- Resistance Level
- DGICB $17.98
- CBLL N/A
- Average True Range (ATR)
- DGICB 0.42
- CBLL 0.00
- MACD
- DGICB 0.02
- CBLL 0.00
- Stochastic Oscillator
- DGICB 77.78
- CBLL 0.00
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.